Aspira Women's Health Inc. SEC filings AWHL

Aspira Women's Health Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (material agreement, new debt). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
10-Q Quarterly report May 19, 2025 Mar 31, 2025
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
10-Q Quarterly report May 11, 2022 Mar 31, 2022
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
10-Q Quarterly report May 14, 2020 Mar 31, 2020
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
10-Q Quarterly report May 14, 2019 Mar 31, 2019
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
10-Q Quarterly report May 14, 2018 Mar 31, 2018
10-Q Quarterly report Nov 8, 2017 Sep 30, 2017
10-Q Quarterly report Aug 11, 2017 Jun 30, 2017
10-Q Quarterly report May 11, 2017 Mar 31, 2017
10-Q Quarterly report Nov 10, 2016 Sep 30, 2016
10-Q Quarterly report Aug 10, 2016 Jun 30, 2016
10-Q Quarterly report May 16, 2016 Mar 31, 2016
10-Q Quarterly report Nov 12, 2015 Sep 30, 2015
10-Q Quarterly report Aug 13, 2015 Jun 30, 2015
10-Q Quarterly report May 12, 2015 Mar 31, 2015
10-Q Quarterly report Nov 13, 2014 Sep 30, 2014
10-Q Quarterly report Aug 14, 2014 Jun 30, 2014
10-Q Quarterly report May 15, 2014 Mar 31, 2014
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
10-Q Quarterly report Aug 14, 2013 Jun 30, 2013
10-Q Quarterly report May 15, 2013 Mar 31, 2013
10-Q Quarterly report Nov 13, 2012 Sep 30, 2012
10-Q Quarterly report Aug 14, 2012 Jun 30, 2012
10-Q Quarterly report May 15, 2012 Mar 31, 2012
10-Q/A Amended quarterly report Jan 17, 2012 Jun 30, 2011
10-Q Quarterly report Nov 9, 2011 Sep 30, 2011

Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
AWHL (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Austin, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
926617
Former names
VERMILLION, INC. (until Jun 10, 2020); CIPHERGEN BIOSYSTEMS INC (until Aug 17, 2007)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.